Skip to main content
. Author manuscript; available in PMC: 2018 Aug 10.
Published in final edited form as: Am J Transplant. 2017 Jan 3;17(5):1334–1345. doi: 10.1111/ajt.14081

Table 6.

Proportion of subjects without improved HRQL at 1-year after lung transplantation defined by either one or two times the minimally clinically important difference

Not improved by at least
the MCID		 Not improved by two times or greater
the MCID
SF12-PCS 11 (8%) 30 (21%)
SF12-MCS 65 (46%) 84 (60%)
AQ20-R 8 (6%) 16 (11%)
EQ5D 50 (35%) 60 (43%)
EQVAS 12 (11%) 27 (25%)

MCID = Minimally Clinically Important Difference; SF12-PCS = Short Form 12 Physical Component Summary scale, MCID=5; SF12-MCS = Short Form 12 Mental Component Summary scale, MCID=5; AQ20-R = Airway Questionnaire 20 – revised, MCID=1.75; EQ5D = Euroqol 5D, MCID=0.06; EQVAS = Euroqol Visual Analog Scale, MCID=10